Frederick L. Locke

Researcher Next ID · RN-005797

Researcher · Medicine

Seoul, South Korea

Not currently recruitingFunding unknown

Research interests

Medicine

Immunology and Microbiology

CAR-T cell therapy research

Lymphoma Diagnosis and Treatment

Multiple Myeloma Research and Treatments

Biosimilars and Bioanalytical Methods

Immunotherapy and Immune Responses

KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
New England Journal of Medicine · 2020 · https://doi.org/10.1056/nejmoa1914347
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
Transplantation and Cellular Therapy · 2018 · https://doi.org/10.1016/j.bbmt.2018.12.758
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial
The Lancet Oncology · 2018 · https://doi.org/10.1016/s1470-2045(18)30864-7
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
New England Journal of Medicine · 2017 · https://doi.org/10.1056/nejmoa1707447
Chimeric antigen receptor T-cell therapy — assessment and management of toxicities
Nature Reviews Clinical Oncology · 2017 · https://doi.org/10.1038/nrclinonc.2017.148

No projects listed.